drugset / Trial / NCT03321942

Treatment of Chronic Renal Failure With Adipose Tissue-derived Mesenchymal Stem Cells

NCT03321942 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

To investigate the biological characteristics of adipose tissue-derived mesenchymal stem cells(AMSCs) and its treatment effects on chronic renal failure.

Timeline

Start
2017-01-01
Primary completion
2018-12-31
Completion
2018-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Adipose tissue derived mesenchymal stem cells Cell therapy — —